Grifols SA (GRFS)
7.34
-0.16
(-2.13%)
USD |
NASDAQ |
Oct 08, 10:31
Grifols Gross Profit Margin (Quarterly) : 37.57% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 37.57% |
| March 31, 2026 | 36.47% |
| December 31, 2025 | 34.66% |
| September 30, 2025 | 39.33% |
| June 30, 2025 | 37.81% |
| March 31, 2025 | 38.90% |
| December 31, 2024 | 38.79% |
| September 30, 2024 | 40.53% |
| June 30, 2024 | 34.15% |
| March 31, 2024 | 38.80% |
| December 31, 2023 | 39.09% |
| September 30, 2023 | 39.42% |
| June 30, 2023 | 34.26% |
| March 31, 2023 | 36.37% |
| March 31, 2021 | 45.02% |
| December 31, 2020 | 45.10% |
| September 30, 2020 | 47.71% |
| June 30, 2020 | 32.32% |
| March 31, 2020 | 45.71% |
| December 31, 2019 | 44.72% |
| September 30, 2019 | 46.15% |
| June 30, 2019 | 47.21% |
| March 31, 2019 | 45.65% |
| December 31, 2018 | 42.36% |
| September 30, 2018 | 45.92% |
| Date | Value |
|---|---|
| June 30, 2018 | 45.35% |
| March 31, 2018 | 47.78% |
| December 31, 2017 | 48.46% |
| September 30, 2017 | 50.23% |
| June 30, 2017 | 47.95% |
| March 31, 2017 | 51.04% |
| December 31, 2016 | 44.04% |
| September 30, 2016 | 44.91% |
| June 30, 2016 | 45.26% |
| March 31, 2016 | 47.49% |
| December 31, 2015 | 47.21% |
| September 30, 2015 | 47.70% |
| June 30, 2015 | 45.98% |
| March 31, 2015 | 47.44% |
| December 31, 2014 | 48.28% |
| September 30, 2014 | 51.61% |
| June 30, 2014 | 46.99% |
| March 31, 2014 | 52.72% |
| December 31, 2013 | 48.62% |
| September 30, 2013 | 51.09% |
| June 30, 2013 | 51.72% |
| March 31, 2013 | 51.19% |
| December 31, 2012 | 49.85% |
| September 30, 2012 | 51.94% |
| June 30, 2012 | 51.51% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| argenx SE | -- |
| Evaxion AS | -- |
| Akari Therapeutics Plc | -- |
| Pharma Mar SA | 86.21% |
| Oryzon Genomics SA | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 7.02% |
| Return on Assets | 2.72% |
| Return on Invested Capital | 3.22% |
| Profit Margin (Quarterly) | 9.77% |
| Operating Margin (Quarterly) | 17.56% |
| Return on Net Operating Assets | 3.01% |